These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11036957)

  • 1. Adjuvant intraportal chemotherapy for Dukes B2 and C colorectal cancer also receiving systemic treatment: results of a multicenter randomized trial. Groupe Régional d'Etude du Cancer Colo-Rectal (Belgium).
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Brohée D; Lecomte M
    Anticancer Drugs; 2000 Aug; 11(7):549-54. PubMed ID: 11036957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: long-term results of a randomized controlled trial.
    Laffer U; Metzger U; Aeberhard P; Lorenz M; Harder F; Maibach R; Zuber M; Herrmann R
    Int J Colorectal Dis; 2008 Dec; 23(12):1233-41. PubMed ID: 18688620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases.
    Rudroff C; Altendorf-Hoffmann A; Stangl R; Scheele J
    Langenbecks Arch Surg; 1999 Jun; 384(3):243-9. PubMed ID: 10437612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
    Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tolerance of adjuvant treatment combining postoperative intraportal chemotherapy and a systemic treatment based on 5-fluorouracil in colorectal carcinoma with a histologically poor prognosis].
    Longree L; Focan C; Dallemagne B; Delforge M; Jehaes C; Malherbe R; Mazy V; Markiewicz S; Weerts J; Lombard R
    Acta Gastroenterol Belg; 1992; 55(4):341-9. PubMed ID: 1462746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK).
    Lancet; 1995 Feb; 345(8946):349-53. PubMed ID: 7845115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma.
    Labianca R; Fossati R; Zaniboni A; Torri V; Marsoni S; Nitti D; Boffi L; Scatizzi M; Tardio B; Mastrodonato N; Banducci S; Consani G; Pancera G;
    J Natl Cancer Inst; 2004 May; 96(10):750-8. PubMed ID: 15150303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-analysis Group.
    J Natl Cancer Inst; 1997 Apr; 89(7):497-505. PubMed ID: 9086006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU.
    Rougier P; Nordlinger B
    Ann Oncol; 1993; 4 Suppl 2():21-8. PubMed ID: 8353101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Final evaluation of the randomized multicenter study SAKK 40/81: adjuvant portal chemotherapy of curatively resected colorectal cancer].
    Laffer U; Metzger U; Aeberhard P; Arigoni M; Arma S; Barras J; Egeli R; Martinoli S; Müller W; Schweizer W
    Helv Chir Acta; 1992 Mar; 58(5):755-8. PubMed ID: 1592650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic recurrence not prevented with low-dosage long-term intraportal 5-FU infusion after resection of colorectal liver metastasis.
    Tsujitani S; Watanabe A; Kakeji Y; Maehara Y; Tomoda H; Furusawa M; Sugimachi K
    Eur J Surg Oncol; 1991 Oct; 17(5):526-9. PubMed ID: 1936301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Status of portal perfusion in colorectal cancer. Swiss Study Group for Clinical Cancer Research].
    Metzger U; Laffer U; Egeli R; Arma S; Aeberhard P; Barras JP; Martinoli S; Müller W; Castiglione M; Schroeder R
    Chirurg; 1994 Jun; 65(6):509-13. PubMed ID: 8088206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized multicenter trial of adjuvant intraportal chemotherapy for colorectal cancer (SAKK 40/81). An interim report.
    Metzger U; Laffer U; Aeberhard P; Arigoni M; Arma S; Barras J; Egeli R; Martinoli S; Mueller W; Schweizer W
    Acta Chir Scand; 1990; 156(6-7):467-74. PubMed ID: 2114722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant regional chemotherapy after hepatic resection for colorectal metastases.
    Ambiru S; Miyazaki M; Ito H; Nakagawa K; Shimizu H; Nakajima N
    Br J Surg; 1999 Aug; 86(8):1025-31. PubMed ID: 10460638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of 5-Fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer.
    Aiura K; Takahashi S; Matsui J; Ueda M; Kitagawa Y
    Pancreatology; 2010; 10(2-3):250-8. PubMed ID: 20484963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of portal infusion chemotherapy for prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer].
    Takano S; Moriguchi M; Seki N; Higaki T; Watanabe Y; Takahashi T; Ito Y; Oishi H; Nakata Y; Kono S
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2176-8. PubMed ID: 7944433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.